Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2001
06/20/2001EP1108021A2 Human genes differentially expressed in colorectal cancer
06/20/2001EP1108020A1 Glycine transporter
06/20/2001EP1108019A2 Protein transport-associated molecules
06/20/2001EP1108014A1 $i(EHRLICHIA CANIS) 120-KDA IMMUNODOMINANT ANTIGENIC PROTEIN AND GENE
06/20/2001EP1108013A2 Genes associated with neurotransmitter processing
06/20/2001EP1108008A1 Novel ubiquitin ligases as therapeutic targets
06/20/2001EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES
06/20/2001EP1107995A2 Bifunctional antibodies and their use in targeting anti-tumour agents
06/20/2001EP1107994A2 Monoclonal antibodies against s100
06/20/2001EP1107993A1 Human monoclonal antibodies directed against the islet cell antigen ia-2
06/20/2001EP1107992A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
06/20/2001EP1107991A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
06/20/2001EP1107990A1 High-affinity antibodies
06/20/2001EP1107987A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
06/20/2001EP1107986A1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same
06/20/2001EP1107977A1 Ratc
06/20/2001EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
06/20/2001EP1107788A1 Scrp-5: secreted cysteine rich protein-5
06/20/2001EP1107774A1 Ramp2a: receptor activity modifying protein-2a
06/20/2001EP1107773A1 METHOD FOR DETECTION OF $i(LEGIONELLA) BACTERIA EMPLOYING PURIFIED ANTIGEN-SPECIFIC ANTIBODIES
06/20/2001EP1107768A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
06/20/2001EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
06/20/2001CN1300367A Methods and compositions for diagnosis of rheumatoid arthritis
06/20/2001CN1300295A Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof
06/20/2001CN1300222A Strategically modified hepatitis b core proteins and their derivatives
06/20/2001CN1299973A HCV-free-blood external preparing method
06/20/2001CN1299870A Lycoris agglutinin protein and its code sequence
06/20/2001CN1299833A Human vessel endothelium growth factor resisting single stranded antibody and its preparation
06/20/2001CN1299832A New human cell cycle regulating protein and its code sequence and use
06/20/2001CN1299831A New interferon-like protein and its code sequence and use
06/20/2001CN1299830A New human heat shock protein and its code sequence and use
06/20/2001CN1299829A New human cell cycle regulating protein and its code sequence and use
06/20/2001CN1299828A New cell factor acceptor and its code sequence and use
06/20/2001CN1299827A New human CD20 homolgous molecule and its code sequence and use
06/20/2001CN1299825A New human zinc finger transcription factor and its code sequence
06/20/2001CN1299824A New human coupling acceptor and its code sequence
06/20/2001CN1299823A New human cell factor and its code sequence and use
06/19/2001US6248872 Nucleotide sequences which code enzymatic protein; for use in detection and treatment of dirofilaria infection
06/19/2001US6248867 Polypeptide associated with proper eye function; for the diagnosis of vision defects
06/19/2001US6248864 Compounds and methods and modulating tissue permeability
06/19/2001US6248863 Phoh homolog
06/19/2001US6248723 Method for treatment of inflammatory disease
06/19/2001US6248712 Urokinase-type plasminogen activator receptor
06/19/2001US6248594 Kinesin-like motor protein
06/19/2001US6248589 Recombinant hepatitis C virus RNA replicase
06/19/2001US6248581 Mycobacteria functional screening and/or expression vectors
06/19/2001US6248576 Histidinol dehydrogenase
06/19/2001US6248574 Fusion protein of polypeptide derived from gp41 or gp120 of defined amino acid sequence and a non-human immunodeficiency virus polypeptide sequence; diagnosis; immunotherapy; immunotoxins; vaccines
06/19/2001US6248565 Immunization with plasmid encoding immunogenic proteins and intracellular targeting sequences
06/19/2001US6248563 Chlamydia trachomatis serotype D genes
06/19/2001US6248561 UCP3 genes
06/19/2001US6248557 RatC
06/19/2001US6248556 Nucleotide sequence of guanosine triphosphate-binding protein from staphylococcus; diagnosis of infections; drug screening; bactericides; bacteriostats; vaccines; probes; primers; vectors; host cells
06/19/2001US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors
06/19/2001US6248554 DNA sequence coding for a BMP receptor
06/19/2001US6248545 Assay of denatured lipoproteins
06/19/2001US6248538 Kit for detecting antibodies against preferential bacteria; for the detection of lyme disease
06/19/2001US6248536 Bacillus thuringiensis CryET33 and CryET34 compositions and uses thereof
06/19/2001US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators
06/19/2001US6248528 Drug screening by contacting test compound with human centrin protein and determining whether compound binds to protein
06/19/2001US6248523 Mammalian tumor susceptibility genes and their uses
06/19/2001US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines
06/19/2001US6248516 Library for expression of immunoglobulin heavy chain variable domains
06/19/2001US6248513 In vitro detection of infection of cells by microorganism; incubate immunoglobulins with cells and detect the formation of protein immunoglobulin complexes
06/19/2001US6248332 Targeted immunostimulation with bispecific reagents
06/19/2001US6248327 Using antibody
06/19/2001US6248326 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/19/2001US6248319 Blood disorders
06/19/2001CA2038577C Utilization and delivery of enzymes
06/14/2001WO2001042787A2 Immunoassay for neonicotinyl insecticides
06/14/2001WO2001042499A1 Method of testing remedy or preventive for hyperlipemia
06/14/2001WO2001042484A1 Il-6 like polynucleotide
06/14/2001WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE
06/14/2001WO2001042471A2 Polypeptides and polynucleotides encoding same
06/14/2001WO2001042465A2 Chordin-like molecules and uses thereof
06/14/2001WO2001042461A2 Apoptin-associating protein
06/14/2001WO2001042451A2 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS
06/14/2001WO2001042450A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof
06/14/2001WO2001042437A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use
06/14/2001WO2001042423A2 Compositions and methods for detecting stress-inducible proteins
06/14/2001WO2001042422A2 Acyl glucosaminyl inositol amidase family and methods of use
06/14/2001WO2001042308A2 Methods and compositions useful for inhibiting ccr5-dependent infection of cells by hiv-1
06/14/2001WO2001042306A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization
06/14/2001WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof
06/14/2001WO2001042304A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
06/14/2001WO2001042301A1 Interferon-alpha induced gene
06/14/2001WO2001042299A2 Hepatitis virus sentinel virus i (svi)
06/14/2001WO2001042288A2 G-protein coupled receptors
06/14/2001WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
06/14/2001WO2001042283A2 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
06/14/2001WO2001041804A1 Modulation and assay of fx activity in cells in cancer, inflammatory responses and diseases and in autoimmunity
06/14/2001WO2001041803A1 COMBINATION OF COMPOUNDS THAT INHIBIT THE BIOLOGICAL EFFECTS OF TNF-α AND CD95L IN A MEDICAMENT
06/14/2001WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof
06/14/2001WO2001041784A1 Methods and compositions for use in the treatment of filovirus mediated disease conditions
06/14/2001WO2001009189A3 Compositions and methods for the treatment of tumors
06/14/2001WO2001000829A8 Human endogenous retrovirus in breast cancer
06/14/2001WO2001000812A3 22012, a novel human carboxypeptidase
06/14/2001WO2000035950A9 Reagents and methods useful for detecting diseases of the breast
06/14/2001US20010003777 Individualized anti-cancer antibodies
06/14/2001US20010003647 Exposing electrochemiluminescent label linked to a coreactant to condition suitable for inducing a electrochemiluminescence